#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune thrombocytopenia Ischaemic stroke Thrombocytosis Squamous cell carcinoma of the oral cavity Mucopolysaccharidosis I Neurotrophic keratopathy Ovarian epithelial cancer Nasopharyngeal cancer Round cell liposarcoma Pancreatic carcinoma metastatic Diffuse large B-cell lymphoma Hepatic angiosarcoma Retinal artery occlusion Ductal adenocarcinoma of pancreas Mitochondrial encephalomyopathy More trials…

    Learn about Rare Diseases

    Usher’s syndrome – Basic Information Waldenstrom’s macroglobulinaemia Alport’s syndrome – Treatment Paroxysmal nocturnal haemoglobinuria – Trials in Disease Alveolar rhabdomyosarcoma – Life with Disease Prader-Willi syndrome – Diagnostics Primary hyperoxaluria – Life with Disease Pulmonary fibrosis – Basic Information Mantle cell lymphoma Myxofibrosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taurine Betaxolol Mitoxantrone ALE.P03 89ZR-CED88004S Bms-986408 L-METHIONINE Mocravimod Bicalutamide L-Histidine Heparin Sodium Fremanezumab Zenocutuzumab Lamivudine Urapidil Ecoo1A Maridebart Cafraglutide Magrolimab Mps-214 Fianlimab More therapies…

    Learn about Your Condition

    Pleomorphic leiomyosarcoma Reperfusion injury Pancreatitis acute Small intestine adenocarcinoma Renal cancer stage IV Diabetic nephropathy Retinal vein occlusion Urea cycle disorder Hyperthyroidism Electronic cigarette user Desmoid tumour Viral myocarditis Pancreatic carcinoma Diabetic retinopathy Right ventricular dysfunction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Pembrolizumab and Paclitaxel for Early Triple-Negative Breast Cancer in Patients with High Tumor-Infiltrating Lymphocytes

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Paclitaxel
    • Pembrolizumab
    France Spain

  • Study on the Effectiveness of Interferon Alfa, Interleukin-1, and Interleukin-2 in Treating Non-Genital Warts in Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Skin papilloma
    Investigated Drugs:
    • Interferon Alfa
    • Interleukin-1
    • Interleukin-2
    Belgium

  • Study for Myelofibrosis Patients Using Ruxolitinib or Ruxolitinib with Other Cancer Treatments

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ruxolitinib
    Poland

  • Long-term Safety Study of CRISPR CAR T Cell Therapy for Patients with Blood and Solid Cancers

    Recruiting

    1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Allogeneic Crispr/Cas9-Mediated Genetically Modified Car T Cells Targeting Cd19 Antigen
    Germany

  • Study on the Safety of Lanreotide and Metformin for Patients with Advanced Gastrointestinal or Lung Carcinoids

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Lung neoplasm malignant
    Investigated Drugs:
    • Metformin Hydrochloride
    • Lanreotide
    Italy

  • Study on Retinoblastoma Treatment: Evaluating the Effectiveness of Topotecan, Vincristine Sulfate, and Etoposide in Patients Eligible for Conservative Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Melphalan Hydrochloride
    • Topotecan
    • Etoposide
    France
Previous Page
1 … 494 495 496 497 498 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!